Skip to main content

Abdominal Lymph Node Anatomy

  • Chapter
  • First Online:
Atlas of Lymph Node Anatomy

Abstract

Lymph node metastases are frequently seen in most primary abdominal malignant tumors. The tumor cells enter lymphatic vessels and travel to the lymph nodes along lymphatic drainage pathways. The lymphatic vessels and lymph nodes generally accompany the blood vessels supplying or draining the organs. They are all located in the subperitoneal space within the ligaments, mesentery, mesocolon, and extra peritoneum. Metastasis to the lymph nodes generally follows the nodal station in a stepwise direction—that is, from the primary tumor to the nodal station that is closest to the primary tumor and then progresses farther away but within the lymphatic drainage pathways. Metastasis to a nodal station that is farther from the primary tumor without involving the nodal station close to the primary tumor (“skip” metastasis) is rare. The key to understanding the pathways of lymphatic drainage of each individual organ is to understand the ligamentous, mesenteric, and peritoneal attachments and the vascular supply of that organ (Meyers et al. Meyers’ dynamic radiology of the abdomen: normal and pathologic anatomy, 2011).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meyers MA, et al. Meyers’ dynamic radiology of the abdomen: normal and pathologic anatomy. 6th ed. New York: Springer-Verlag; 2011.

    Book  Google Scholar 

  2. McDaniel KP, Charnsangavej C, DuBrow RA, Varma DG, Granfield CA, Curley SA. Pathways of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT demonstration. AJR Am J Roentgenol. 1993;161(1):61–4. https://doi.org/10.2214/ajr.161.1.8517322.

    Article  CAS  PubMed  Google Scholar 

  3. Granfield CA, Charnsangavej C, Dubrow RA, Varma DG, Curley SA, Whitley NO, et al. Regional lymph node metastases in carcinoma of the left side of the colon and rectum: CT demonstration. AJR Am J Roentgenol. 1992;159(4):757–61. https://doi.org/10.2214/ajr.159.4.1529837.

    Article  CAS  PubMed  Google Scholar 

  4. Gest TPP. Anatomy: medcharts. New York: Iloc; 1994.

    Google Scholar 

  5. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology. 1991;180(2):319–22. https://doi.org/10.1148/radiology.180.2.2068292.

    Article  CAS  PubMed  Google Scholar 

  6. Dodd GD, Baron RL, Oliver JH, Federle MP, Baumgartel PB. Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology. 1997;203(1):127–30. https://doi.org/10.1148/radiology.203.1.9122379.

    Article  PubMed  Google Scholar 

  7. Morón FE, Szklaruk J. Learning the nodal stations in the abdomen. Br J Radiol. 2007;80(958):841–8. https://doi.org/10.1259/bjr/64292252.

    Article  PubMed  Google Scholar 

  8. Harisinghani MG, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491–9. https://doi.org/10.1056/NEJMoa022749.

    Article  PubMed  Google Scholar 

  9. Mao Y, Hedgire S, Harisinghani M. Radiologic assessment of lymph nodes in oncologic patients. Curr Radiol Rep. 2013;2(2):36. https://doi.org/10.1007/s40134-013-0036-6.

    Article  CAS  Google Scholar 

  10. Neuwelt A, Sidhu N, Hu C-AA, Mlady G, Eberhardt SC, Sillerud LO. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. AJR Am J Roentgenol. 2015;204(3):W302–13. https://doi.org/10.2214/AJR.14.12733.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gauthé M, et al. Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers. Dig Liver Dis. 2015;47(6):443–54. https://doi.org/10.1016/j.dld.2015.02.005.

    Article  PubMed  Google Scholar 

  12. Harisinghani MG, et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol. 2006;186(1):144–8. https://doi.org/10.2214/AJR.04.1287.

    Article  PubMed  Google Scholar 

  13. Frija J, Bourrier P, Zagdanski AM, De Kerviler E. Diagnosis of a malignant lymph node. J Radiol. 2005;86(2 Pt 1):113–25. https://doi.org/10.1016/s0221-0363(05)81331-9.

    Article  CAS  PubMed  Google Scholar 

  14. Egner JR. AJCC cancer staging manual. JAMA. 2010;304(15):1726–7. https://doi.org/10.1001/jama.2010.1525.

    Article  CAS  Google Scholar 

  15. Kobayashi S, et al. Surgical treatment of lymph node metastases from hepatocellular carcinoma. J Hepato-Biliary-Pancreat Sci. 2011;18(4):559–66. https://doi.org/10.1007/s00534-011-0372-y.

    Article  Google Scholar 

  16. Xia F, et al. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. 2014;9(4):e95889. https://doi.org/10.1371/journal.pone.0095889.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Pan T, et al. Percutaneous CT-guided radiofrequency ablation for lymph node oligometastases from hepatocellular carcinoma: a propensity score–matching analysis. Radiology. 2016;282(1):259–70. https://doi.org/10.1148/radiol.2016151807.

    Article  PubMed  Google Scholar 

  18. Clark HP, Carson WF, Kavanagh PV, Ho CPH, Shen P, Zagoria RJ. Staging and current treatment of hepatocellular carcinoma. Radiographics. 2005;25(Suppl 1):S3–23. https://doi.org/10.1148/rg.25si055507.

    Article  PubMed  Google Scholar 

  19. Kalogeridi M-A, et al. Role of radiotherapy in the management of hepatocellular carcinoma: a systematic review. World J Hepatol. 2015;7(1):101–12. https://doi.org/10.4254/wjh.v7.i1.101.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wu H, Liu S, Zheng J, Ji G, Han J, Xie Y. Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma. J Surg Oncol. 2015;112(4):372–6. https://doi.org/10.1002/jso.23994.

    Article  PubMed  Google Scholar 

  21. Hartgrink HH, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069–77. https://doi.org/10.1200/JCO.2004.08.026.

    Article  CAS  PubMed  Google Scholar 

  22. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2016;27:v38–49. https://doi.org/10.1093/annonc/mdw350.

    Article  CAS  PubMed  Google Scholar 

  23. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19. https://doi.org/10.1007/s10120-016-0622-4.

    Article  Google Scholar 

  24. Young JJ, et al. Ligaments and lymphatic pathways in gastric adenocarcinoma. Radiographics. 2019;39(3):668–89. https://doi.org/10.1148/rg.2019180113.

    Article  PubMed  Google Scholar 

  25. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241(1):27–39. https://doi.org/10.1097/01.sla.0000149300.28588.23.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99(4):199–206. https://doi.org/10.1002/jso.21224.

    Article  PubMed  Google Scholar 

  27. Ong MLH, Schofield JB. Assessment of lymph node involvement in colorectal cancer. World J Gastrointest Surg. 2016;8(3):179–92. https://doi.org/10.4240/wjgs.v8.i3.179.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Taylor FGM, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. Am J Roentgenol. 2008;191(6):1827–35. https://doi.org/10.2214/AJR.08.1004.

    Article  Google Scholar 

  29. Steup WH, Moriya Y, van de Velde CJH. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer. 2002;38(7):911–8. https://doi.org/10.1016/s0959-8049(02)00046-1.

    Article  CAS  PubMed  Google Scholar 

  30. Rajput A, et al. Meeting the 12 lymph node (LN) benchmark in colon cancer. J Surg Oncol. 2010;102(1):3–9. https://doi.org/10.1002/jso.21532.

    Article  CAS  PubMed  Google Scholar 

  31. Wolpin BM, Meyerhardt JA, Mamon HJ, Mayer RJ. Adjuvant treatment of colorectal cancer. CA Cancer J Clin. 2007;57(3):168–85. https://doi.org/10.3322/canjclin.57.3.168.

    Article  PubMed  Google Scholar 

  32. Koh D-M, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. Am J Roentgenol. 2010;194(6):W505–13. https://doi.org/10.2214/AJR.08.1819.

    Article  Google Scholar 

  33. Pozo ME, Fang SH. Watch and wait approach to rectal cancer: a review. World J Gastrointest Surg. 2015;7(11):306–12. https://doi.org/10.4240/wjgs.v7.i11.306.

    Article  PubMed  PubMed Central  Google Scholar 

  34. American Cancer Society. Cancer facts & figures 2020. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2020.html. Accessed 11 Oct 2020.

  35. Karakiewicz PI, et al. Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol. 2006;50(3):521–8; discussion 529. https://doi.org/10.1016/j.eururo.2006.02.034.

    Article  PubMed  Google Scholar 

  36. Lughezzani G, et al. Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective. Cancer. 2009;115(24):5680–7. https://doi.org/10.1002/cncr.24682.

    Article  PubMed  Google Scholar 

  37. Capitanio U, et al. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int. 2009;103(1):33–7. https://doi.org/10.1111/j.1464-410X.2008.08014.x.

    Article  PubMed  Google Scholar 

  38. Tadayoni A, Paschall AK, Malayeri AA. Assessing lymph node status in patients with kidney cancer. Transl Androl Urol. 2018;7(5):766–73. https://doi.org/10.21037/tau.2018.07.19.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Israel GM, Bosniak MA. Renal imaging for diagnosis and staging of renal cell carcinoma. Urol Clin North Am. 2003;30(3):499–514. https://doi.org/10.1016/s0094-0143(03)00019-3.

    Article  PubMed  Google Scholar 

  40. Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol. 1997;65(3):164–70. https://doi.org/10.1002/(sici)1096-9098(199707)65:3<164::aid-jso4>3.0.co;2-4.

    Article  CAS  PubMed  Google Scholar 

  41. Kayahara M, Nakagawara H, Kitagawa H, Ohta T. The nature of neural invasion by pancreatic cancer. Pancreas. 2007;35(3):218–23. https://doi.org/10.1097/mpa.0b013e3180619677.

    Article  PubMed  Google Scholar 

  42. Pawlik TM, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141(5):610–8. https://doi.org/10.1016/j.surg.2006.12.013.

    Article  PubMed  Google Scholar 

  43. Wong JC, Raman S. Surgical resectability of pancreatic adenocarcinoma: CTA. Abdom Imaging. 2010;35(4):471–80. https://doi.org/10.1007/s00261-009-9539-2.

    Article  PubMed  Google Scholar 

  44. Laeseke PF, Chen R, Jeffrey RB, Brentnall TA, Willmann JK. Combining in vitro diagnostics with in vivo imaging for earlier detection of pancreatic ductal adenocarcinoma: challenges and solutions. Radiology. 2015;277(3):644–61. https://doi.org/10.1148/radiol.2015141020. Accessed 5 Oct 2020.

    Article  PubMed  Google Scholar 

  45. Pietryga JA, Morgan DE. Imaging preoperatively for pancreatic adenocarcinoma. J Gastrointest Oncol. 2015;6(4):343–57. https://doi.org/10.3978/j.issn.2078-6891.2015.024.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Cameron K, et al. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT). Abdom Imaging. 2011;36(4):463–71. https://doi.org/10.1007/s00261-011-9729-6.

    Article  PubMed  Google Scholar 

  47. Parlak C, Topkan E, Onal C, Reyhan M, Selek U. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Radiat Oncol. 2012;7(1):37. https://doi.org/10.1186/1748-717X-7-37.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mukesh G. Harisinghani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shakur, A., O’Shea, A., Harisinghani, M.G. (2021). Abdominal Lymph Node Anatomy. In: Harisinghani, M.G. (eds) Atlas of Lymph Node Anatomy. Springer, Cham. https://doi.org/10.1007/978-3-030-80899-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80899-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80898-3

  • Online ISBN: 978-3-030-80899-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics